MID ATLANTIC RESEARCH CENTER FOR HEALTH

Bringing Medicine To The Market Place

Recent clinical trials conducted at M-A-R-C-H

A randomized, double-blind, vehicle-controlled, multicenter, parallel group study to assess the efficacy, safety, and tolerability of topical terbinafine hydrogen chloride (HCL) formulation for 24 or 48 weeks of treatment in patients with mild to moderate toenail onychomycosis

A randomized, open label, multi-center trial to investigate the efficacy and safety of 12 weeks oral terbinafine (250-mg q.d.) with and without nail debridement in the treatment of onychomycosis

A randomized, double-blind, vehicle-controlled, multi-center study to evaluate the efficacy and safety of SCH 900340 5% solution administered topically in the treatment of distal subungual onychomycosis of the toenail

An investigator-blinded study comparing the efficacy and safety of four Posaconazole treatment regimens with placebo and Terbinafine in the treatment of onychomycosis of the toenail

A randomized, controlled, open-label study to investigate the safety and efficacy of a topical Gentamicin-Collagen sponge (CollatempG) compared to Levofloxacin in diabetic patients wild mild infection of a lower extremity skin ulcer

SFO327N2302, Terbinafine HCL NSO

P05082

P05204

CSFO327KUS14

INN-TOP-001

Project List

CSAH100A2302

 

An 8-week, double-blind, randomized, parallel group, active-controlled study to evaluate the efficacy and safety of the combination of Aliskiren / Amlodipine / HCTZ in patients with moderate to sever hypertension.